These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
689 related articles for article (PubMed ID: 27688191)
1. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents. Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191 [TBL] [Abstract][Full Text] [Related]
2. GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates. Liu R; Fu Z; Zhao M; Gao X; Li H; Mi Q; Liu P; Yang J; Yao Z; Gao Q Oncotarget; 2017 Jun; 8(24):39476-39496. PubMed ID: 28467806 [TBL] [Abstract][Full Text] [Related]
3. Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer. Wu M; Li H; Liu R; Gao X; Zhang M; Liu P; Fu Z; Yang J; Zhang-Negrerie D; Gao Q Eur J Med Chem; 2016 Mar; 110():32-42. PubMed ID: 26807543 [TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects. Han J; Gao X; Liu R; Yang J; Zhang M; Mi Y; Shi Y; Gao Q Chem Biol Drug Des; 2016 Jun; 87(6):867-77. PubMed ID: 26706102 [TBL] [Abstract][Full Text] [Related]
5. Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism. Li T; Gao X; Yang L; Shi Y; Gao Q ChemMedChem; 2016 May; 11(10):1069-77. PubMed ID: 27135196 [TBL] [Abstract][Full Text] [Related]
6. Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action. Li H; Gao X; Liu R; Wang Y; Zhang M; Fu Z; Mi Y; Wang Y; Yao Z; Gao Q Eur J Med Chem; 2015 Aug; 101():400-8. PubMed ID: 26177447 [TBL] [Abstract][Full Text] [Related]
7. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation. Wang H; Yang X; Zhao C; Wang PG; Wang X Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077 [TBL] [Abstract][Full Text] [Related]
8. 2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity. Mi Q; Ma Y; Gao X; Liu R; Liu P; Mi Y; Fu X; Gao Q J Biomol Struct Dyn; 2016 Nov; 34(11):2339-50. PubMed ID: 26524393 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers. Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964 [TBL] [Abstract][Full Text] [Related]
10. Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo. Patra M; Awuah SG; Lippard SJ J Am Chem Soc; 2016 Sep; 138(38):12541-51. PubMed ID: 27570149 [TBL] [Abstract][Full Text] [Related]
11. Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties. Liu P; Lu Y; Gao X; Liu R; Zhang-Negrerie D; Shi Y; Wang Y; Wang S; Gao Q Chem Commun (Camb); 2013 Mar; 49(24):2421-3. PubMed ID: 23420130 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles. Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770 [TBL] [Abstract][Full Text] [Related]
13. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH; al-Baker S; Thai G; Khokhar AR Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929 [TBL] [Abstract][Full Text] [Related]
14. Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery. Ma J; Wang Q; Huang Z; Yang X; Nie Q; Hao W; Wang PG; Wang X J Med Chem; 2017 Jul; 60(13):5736-5748. PubMed ID: 28603992 [TBL] [Abstract][Full Text] [Related]
15. Mannose-conjugated platinum complexes reveals effective tumor targeting mediated by glucose transporter 1. Liu R; Li H; Gao X; Mi Q; Zhao H; Gao Q Biochem Biophys Res Commun; 2017 May; 487(1):34-40. PubMed ID: 28385528 [TBL] [Abstract][Full Text] [Related]
17. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs. Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112 [TBL] [Abstract][Full Text] [Related]
18. Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo. Ma J; Yang X; Hao W; Huang Z; Wang X; Wang PG Eur J Med Chem; 2017 Mar; 128():45-55. PubMed ID: 28147308 [TBL] [Abstract][Full Text] [Related]
19. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1 Papadia P; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N Dalton Trans; 2021 Nov; 50(43):15655-15668. PubMed ID: 34673864 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes. Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]